KBS - Pharmaceutical Consultancy and Life Sciences - Market Insight

The acquisition of Fortis, a London-based specialist in medical affairs services, added rich industry-side expertise to complement the deep scientific heritage of Bioscript, a unified full-service pharmaceutical communications company. FORTIS PHARMA CONSULTING ACQUIRED BY BIOSCRIPT GROUP

Zeta Analytics, an established and trusted provider of independent testing for licensed human, veterinary and medical products, working with prestigious, multinational clients in the pharmaceutical sector, was sold to Phenna Group, which was making a second ac-quisition through KBS following IASME Consortium. ZETA ANALYTICS ACQUIRED BY PHENNA GROUP KBS DEAL Kalon specialises in the development and production of medical diagnostic kits and commercial enzyme immunoassays EIA kits for the healthcare industry. The company was bought by Calibre Scientific, a diversified global provider of reagents, tools and other products to the healthcare, laboratory and biopharmaceutical industries. KALON BIOLOGICAL ACQUIRED BY CALIBRE SCIENTIFIC KBS DEAL GM is a leading manufacturer and supplier of a diverse range of ENT (ORL) electronic medical instruments including nasal measurement instrumentation, screening audiome-ters and accessories and respiratory flowheads, in addition to calibration and support facilities. The company was acquired by HCE, recognised as one of the UK’s leading distrib-utors of medical/orthopaedic supplies and equipment pharmaceuticals. GM INSTRUMENTS ACQUIRED BY HCE MEDICAL GROUP KBS DEAL

CELLO HEALTH ACQUIRED BY PHARMA VALUE DEMONSTRATION BIDCO

Cello Health, a global healthcare-focused advisory firm which services 24 of the top 25 pharmaceutical clients, was acquired by Arsenal Capital Partners through Pharma Value Demonstration Bidco in a transaction that valued the company at around £179million.